ImprimisRx CA, Inc., dba ImprimisRx
FDA Regulatory Profile
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 2
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-1132-2017 | Class II | Timolol-Latanoprost PF Solution (0.5-0.005)%, Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a | June 23, 2017 |
| D-1130-2017 | Class II | Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL Multiple Dose Vial, For Slow IV Administration, C | June 23, 2017 |
| D-1131-2017 | Class II | Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed | June 23, 2017 |
| D-1133-2017 | Class II | Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle | June 23, 2017 |